134 related articles for article (PubMed ID: 3020160)
1. Independent regulation of the antiviral states induced by MuIFN-alpha/beta and by MuIFN-gamma.
Ramamurthy V; Fleischmann R
J Gen Virol; 1986 Oct; 67 ( Pt 10)():2223-6. PubMed ID: 3020160
[TBL] [Abstract][Full Text] [Related]
2. Regulation of interferon-induced antiviral states: contrasting profiles of decay in response to the removal of MuIFN-alpha, MuIFN-beta and MuIFN-gamma.
Ramamurthy V; Fleischmann WR
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1645-52. PubMed ID: 3016159
[TBL] [Abstract][Full Text] [Related]
3. Regulation of MuIFN-alpha/beta and MuIFN-gamma-induced antiviral states: differential effects with different challenge viruses and lack of correlation with 2'5' oligoadenylate synthetase levels.
Ramamurthy V; Fleischmann WR
J Biol Regul Homeost Agents; 1988; 2(1):7-14. PubMed ID: 2845725
[TBL] [Abstract][Full Text] [Related]
4. Effect of hyperthermia on the antiproliferative activities of murine alpha-, beta-, and gamma-interferon: differential enhancement of murine gamma-interferon.
Fleischmann WR; Fleischmann CM; Gindhart TD
Cancer Res; 1986 Jan; 46(1):8-13. PubMed ID: 2998611
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of interferon's antiviral activity by the mutually synergistic interaction of MuIFN-alpha/beta and MuIFN-gamma.
Schwarz LA; Fleischmann CM; Fleischmann WR
J Biol Response Mod; 1984 Dec; 3(6):608-12. PubMed ID: 6096507
[TBL] [Abstract][Full Text] [Related]
6. Differential antiproliferative activities of IFNs alpha, beta and gamma: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs alpha and beta.
Fleischmann CM; Fleischmann WR
J Biol Regul Homeost Agents; 1988; 2(4):173-85. PubMed ID: 3150645
[TBL] [Abstract][Full Text] [Related]
7. Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself.
Fleischmann WR; Fleischmann CM
Antiviral Res; 1984 Aug; 4(4):221-8. PubMed ID: 6091541
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of various classes of mouse interferons on macrophage activation for tumor cell killing.
Pace JL; Russell SW; LeBlanc PA; Murasko DM
J Immunol; 1985 Feb; 134(2):977-81. PubMed ID: 2578167
[TBL] [Abstract][Full Text] [Related]
9. In vivo myelosuppression by combination interferon treatment: antagonism of MuIFN-gamma and MuIFN-beta myelosuppressive effects.
Naldini A; Fleischmann WR
J Biol Response Mod; 1987 Oct; 6(5):546-55. PubMed ID: 3119781
[TBL] [Abstract][Full Text] [Related]
10. Resistance to the antiproliferative activity of IFN-alpha: further characterization and demonstration of antagonistic effects of IFN-gamma.
Fleischmann CM; Fleischmann WR
J Biol Regul Homeost Agents; 1991; 5(1):34-42. PubMed ID: 1909084
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interactions between IFN-gamma and IFN-beta in priming murine macrophages for tumor cell killing.
Pace JL
J Leukoc Biol; 1988 Dec; 44(6):514-20. PubMed ID: 3142957
[TBL] [Abstract][Full Text] [Related]
12. Requirement for IFN gamma in potentiation of interferon's antiviral and anticellular activities: identity of mouse and human systems.
Fleischmann WR; Schwarz LA; Fleischmann CM
J Interferon Res; 1984; 4(2):265-74. PubMed ID: 6431021
[TBL] [Abstract][Full Text] [Related]
13. Studies on the expression of spontaneous and induced interferons in mouse peritoneal macrophages by means of monoclonal antibodies to mouse interferons.
Belardelli F; Gessani S; Proietti E; Locardi C; Borghi P; Watanabe Y; Kawade Y; Gresser I
J Gen Virol; 1987 Aug; 68 ( Pt 8)():2203-12. PubMed ID: 3039046
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells.
Schijns VE; Van der Neut R; Haagmans BL; Bar DR; Schellekens H; Horzinek MC
J Gen Virol; 1991 Apr; 72 ( Pt 4)():809-15. PubMed ID: 1849968
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
16. Prevention of resistance to IFN-alpha antiproliferative activity: characterization of the effect of IFN-gamma and substitution for IFN-gamma by tumor necrosis factor.
Fleischmann CM; Stanton GJ; Fleischmann WR
J Biol Regul Homeost Agents; 1993; 7(2):50-7. PubMed ID: 8266815
[TBL] [Abstract][Full Text] [Related]
17. Treatment of mice with macrophage colony stimulating factor (CSF-1) prevents the in vivo myelosuppression induced by murine alpha, beta, and gamma interferons.
Koren S; Klimpel GR; Fleischmann WR
J Biol Response Mod; 1986 Oct; 5(5):481-9. PubMed ID: 3095498
[TBL] [Abstract][Full Text] [Related]
18. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
Kandefer-Szerszeń M
Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
[TBL] [Abstract][Full Text] [Related]
19. Regulation of interferon-beta activity by fibroblast cells.
Ramamurthy V; Fleischmann WR
Antiviral Res; 1986 Aug; 6(5):267-75. PubMed ID: 3094445
[TBL] [Abstract][Full Text] [Related]
20. Human interferons alpha and beta have more potent priming activities than interferon gamma.
Tóth M; Endrész V; Tóth S; Béládi I
J Gen Virol; 1985 Apr; 66 ( Pt 4)():893-6. PubMed ID: 2580053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
